Award
Delivery Order #SPE2DR26FL483
Delivery Order for Novolog Vials by AmerisourceBergen Drug Corp
Buyer
Defense Logistics Agency
Award Amount
$527.40
Ceiling
$527.40
Awarded
March 11, 2026
Period of Performance
Mar 11, 2026 – Mar 12, 2026
Identifier
SPE2DR26FL483
NAICS
424210
This award represents a delivery order contract placed with AmerisourceBergen Drug Corp, a prominent pharmaceutical distribution company known for its wide-ranging healthcare solutions. The contract involves the procurement of Novolog insulin in 100 unit/ml 10ml vials, a critical medication for diabetes management. This delivery order extends for a short-term period and is part of a broader indefinite delivery/indefinite quantity (IDIQ) contract aimed at providing pharmaceutical products to healthcare agencies, ensuring reliable and timely access to essential medications. The order contributes to maintaining an efficient supply chain, supporting patient care across health services. The contract was awarded as a part of a competitive vehicle under the parent IDIQ award, facilitating flexible procurement under established terms. The delivery is set to occur over a concise timeframe, reinforcing quick fulfillment within ongoing pharmaceutical supply efforts.
Description
4571119082!NOVOLOG 100 UNIT/ML VIAL 10ML